$GLGC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ORE PHARMACEUTICAL HOLDINGS INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ORE PHARMACEUTICAL HOLDINGS INC.. Get notifications about new insider transactions in ORE PHARMACEUTICAL HOLDINGS INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 29 2010 | GLGC | ORE PHARMACEUTICAL ... | Steel Partners, Ltd. | 10% Owner | Buy | P | 0.26 | 68,000 | 17,340 | 3,568,000 | 3.5 M to 3.6 M (+1.94 %) |
Oct 29 2010 | GLGC | ORE PHARMACEUTICAL ... | Steel Partners, Ltd. | 10% Owner | Buy | P | 0.26 | 125,000 | 31,875 | 3,500,000 | 3.4 M to 3.5 M (+3.70 %) |
Jan 20 2010 | GLGC | ORE PHARMACEUTICAL ... | Donahue Stephen R | Senior Vice Preside ... | Option Exercise | A | 0.57 | 2,500 | 1,425 | 2,500 | |
Jan 20 2010 | GLGC | ORE PHARMACEUTICAL ... | Palleiko Benjamin L | SVP & Chief Financi ... | Option Exercise | A | 0.57 | 6,250 | 3,563 | 6,250 | |
Dec 02 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.62 | 2,000 | 1,240 | 14,000 | 12 K to 14 K (+16.67 %) |
Dec 01 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.55 | 2,000 | 1,100 | 10,000 | 8 K to 10 K (+25.00 %) |
Nov 25 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.58 | 2,000 | 1,150 | 8,000 | 6 K to 8 K (+33.33 %) |
Nov 25 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.58 | 2,000 | 1,150 | 6,000 | 4 K to 6 K (+50.00 %) |
Nov 23 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.62 | 20 | 12 | 10,000 | 10 K to 10 K (+0.20 %) |
Nov 23 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.64 | 1,980 | 1,267 | 9,980 | 8 K to 10 K (+24.75 %) |
Nov 23 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.62 | 2,000 | 1,240 | 8,000 | 6 K to 8 K (+33.33 %) |
Nov 23 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.64 | 2,000 | 1,280 | 4,000 | 2 K to 4 K (+100.00 %) |
Nov 20 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.63 | 1,700 | 1,077 | 2,000 | 300 to 2 K (+566.67 %) |
Nov 20 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Buy | P | 0.63 | 300 | 190 | 300 | 0 to 300 |
Oct 22 2009 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 0.73 | 40,000 | 29,048 | 40,000 | |
Oct 22 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Option Exercise | A | 0.73 | 40,000 | 29,048 | 40,000 | |
Oct 22 2009 | GLGC | ORE PHARMACEUTICAL ... | URDAL DAVID | Director | Option Exercise | A | 0.73 | 40,000 | 29,048 | 40,000 | |
Oct 22 2009 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | A | 0.73 | 40,000 | 29,048 | 40,000 | |
Aug 28 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.58 | 2,000 | 1,160 | 6,000 | 4 K to 6 K (+50.00 %) |
Aug 19 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Chief Executive Off ... | Buy | P | 0.60 | 2,000 | 1,190 | 4,000 | 2 K to 4 K (+100.00 %) |
Aug 04 2009 | GLGC | ORE PHARMACEUTICAL ... | FORDYCE JAMES W | Director | Option Exercise | A | 0.62 | 6,000 | 3,719 | 6,000 | |
Jul 17 2009 | GLGC | ORE PHARMACEUTICAL ... | Palleiko Benjamin L | SVP & Chief Financi ... | Option Exercise | A | 0.55 | 125,000 | 68,450 | 125,000 | |
Jul 17 2009 | GLGC | ORE PHARMACEUTICAL ... | Palleiko Benjamin L | SVP & Chief Financi ... | Option Exercise | A | 0.55 | 115,000 | 62,974 | 115,000 | |
Jun 11 2009 | GLGC | ORE PHARMACEUTICAL ... | Donahue Stephen R | Senior Vice Preside ... | Option Exercise | A | 0.55 | 100,000 | 55,000 | 100,000 | |
Apr 15 2009 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Director | Option Exercise | A | 0.40 | 500,000 | 200,000 | 500,000 | |
May 27 2008 | GLGC | ORE PHARMACEUTICAL ... | URDAL DAVID | Director | Option Exercise | A | 1.70 | 3,000 | 5,100 | 3,000 | |
May 27 2008 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 1.70 | 4,000 | 6,800 | 4,000 | |
May 27 2008 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | A | 1.70 | 3,000 | 5,100 | 3,000 | |
May 27 2008 | GLGC | ORE PHARMACEUTICAL ... | GESSLER MARK D | Director | Option Exercise | A | 1.70 | 3,000 | 5,100 | 3,000 | |
May 27 2008 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Director | Option Exercise | A | 1.70 | 3,000 | 5,100 | 3,000 | |
Apr 25 2008 | GLGC | ORE PHARMACEUTICAL ... | Tiffany Larry M | SVP & Interim GM Ge ... | Option Exercise | A | 0.44 | 29,400 | 12,936 | 29,400 | |
Apr 25 2008 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Option Exercise | A | 0.44 | 117,600 | 51,744 | 117,600 | |
Apr 25 2008 | GLGC | ORE PHARMACEUTICAL ... | ROHRER PHILIP L JR | Chief Financial Off ... | Option Exercise | A | 0.44 | 117,600 | 51,744 | 117,600 | |
Apr 25 2008 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Option Exercise | A | 0.44 | 235,200 | 103,488 | 235,200 | |
Mar 24 2008 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Grant | A | 1.37 | 50,000 | 68,500 | 252,493 | 202.5 K to 252.5 K (+24.69 %) |
Mar 18 2008 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Option Exercise | D | 1.91 | 30,000 | 57,300 | 0 | ||
Mar 18 2008 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Sell | D | 0.71 | 2,334,712 | 1,655,311 | 0 | 2.3 M to 0 (-100.00 %) | |
Mar 18 2008 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Sell | D | 0.71 | 2,267,415 | 1,607,597 | 0 | 2.3 M to 0 (-100.00 %) | |
Mar 18 2008 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Buy | P | 0.71 | 1,375,765 | 975,417 | 2,267,415 | 891.7 K to 2.3 M (+154.29 %) | |
Mar 18 2008 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Sell | S | 0.71 | 1,375,765 | 975,417 | 0 | 1.4 M to 0 (-100.00 %) | |
Dec 18 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Grant | A | 0.00 | 25,000 | 0 | 202,493 | 177.5 K to 202.5 K (+14.09 %) |
Dec 18 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Grant | A | 0.00 | 15,484 | 0 | 18,484 | 3 K to 18.5 K (+516.13 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.95 | 8,200 | 7,790 | 177,493 | 169.3 K to 177.5 K (+4.84 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.95 | 800 | 758 | 169,293 | 168.5 K to 169.3 K (+0.47 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.94 | 6,700 | 6,297 | 168,493 | 161.8 K to 168.5 K (+4.14 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.95 | 1,300 | 1,234 | 161,793 | 160.5 K to 161.8 K (+0.81 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.95 | 2,700 | 2,565 | 160,493 | 157.8 K to 160.5 K (+1.71 %) |
Nov 30 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.94 | 12,300 | 11,562 | 157,793 | 145.5 K to 157.8 K (+8.45 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.89 | 2,500 | 2,225 | 145,493 | 143 K to 145.5 K (+1.75 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.90 | 800 | 720 | 142,993 | 142.2 K to 143 K (+0.56 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.92 | 4,100 | 3,772 | 142,193 | 138.1 K to 142.2 K (+2.97 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.92 | 18,400 | 16,928 | 138,093 | 119.7 K to 138.1 K (+15.37 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.88 | 9,885 | 8,699 | 119,693 | 109.8 K to 119.7 K (+9.00 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Director | Buy | P | 0.90 | 50,000 | 45,000 | 891,650 | 841.7 K to 891.7 K (+5.94 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Director | Buy | P | 0.79 | 100 | 79 | 841,650 | 841.6 K to 841.7 K (+0.01 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Director | Buy | P | 0.80 | 1,340 | 1,072 | 841,550 | 840.2 K to 841.6 K (+0.16 %) |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Director | Buy | P | 0.85 | 10,000 | 8,500 | 840,210 | 830.2 K to 840.2 K (+1.20 %) |
Nov 28 2007 | GLGC | ORE PHARMACEUTICAL ... | URDAL DAVID | Director | Buy | P | 0.90 | 25,000 | 22,500 | 25,000 | 0 to 25 K |
Nov 29 2007 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Director | Buy | P | 0.94 | 10,000 | 9,374 | 10,000 | 0 to 10 K |
Nov 28 2007 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Buy | P | 0.85 | 7,967 | 6,772 | 22,000 | 14 K to 22 K (+56.77 %) |
Nov 28 2007 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Buy | P | 0.84 | 3,300 | 2,772 | 14,033 | 10.7 K to 14 K (+30.75 %) |
Nov 28 2007 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Buy | P | 0.83 | 3,733 | 3,098 | 10,733 | 7 K to 10.7 K (+53.33 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.81 | 60 | 48 | 109,808 | 109.7 K to 109.8 K (+0.05 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.85 | 7,500 | 6,375 | 109,748 | 102.2 K to 109.7 K (+7.34 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.82 | 1,700 | 1,394 | 102,248 | 100.5 K to 102.2 K (+1.69 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.85 | 17,900 | 15,215 | 100,548 | 82.6 K to 100.5 K (+21.66 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.81 | 2,840 | 2,300 | 82,648 | 79.8 K to 82.6 K (+3.56 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.83 | 4,483 | 3,721 | 79,808 | 75.3 K to 79.8 K (+5.95 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.82 | 6,425 | 5,269 | 75,325 | 68.9 K to 75.3 K (+9.33 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.79 | 27,641 | 21,836 | 68,900 | 41.3 K to 68.9 K (+66.99 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | P | 0.80 | 2,359 | 1,887 | 41,259 | 38.9 K to 41.3 K (+6.06 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 0.83 | 4,500 | 3,717 | 17,000 | 12.5 K to 17 K (+36.00 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 0.83 | 100 | 83 | 12,500 | 12.4 K to 12.5 K (+0.81 %) |
Nov 27 2007 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 0.82 | 2,400 | 1,968 | 12,400 | 10 K to 12.4 K (+24.00 %) |
Oct 19 2007 | GLGC | ORE PHARMACEUTICAL ... | Douglas Frank L | Director | Option Exercise | A | 1.49 | 15,000 | 22,350 | 15,000 | |
Jul 11 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Option Exercise | A | 1.37 | 120,000 | 164,400 | 120,000 | |
Jul 11 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | J | 1.37 | 25,000 | 34,250 | 25,000 | 0 to 25 K |
Jul 11 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | J | 1.37 | 30,000 | 41,100 | 30,000 | 0 to 30 K |
Jul 11 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Buy | J | 1.37 | 25,000 | 34,250 | 25,000 | 0 to 25 K |
Jul 11 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | CEO & President | Grant | A | 1.37 | 50,000 | 68,500 | 50,000 | 0 to 50 K |
Jun 07 2007 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 1.49 | 20,000 | 29,800 | 20,000 | |
Apr 11 2007 | GLGC | ORE PHARMACEUTICAL ... | URDAL DAVID | Director | Option Exercise | A | 2.29 | 30,000 | 68,700 | 30,000 | |
Jun 07 2007 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | A | 1.49 | 15,000 | 22,350 | 15,000 | |
Apr 11 2007 | GLGC | ORE PHARMACEUTICAL ... | Gabrielson Mark J | Director | Option Exercise | A | 2.29 | 30,000 | 68,700 | 30,000 | |
Mar 02 2007 | GLGC | ORE PHARMACEUTICAL ... | GESSLER MARK D | CEO and President | Buy | P | 1.80 | 51,119 | 92,014 | 247,640 | 196.5 K to 247.6 K (+26.01 %) |
Mar 02 2007 | GLGC | ORE PHARMACEUTICAL ... | BRENNAN MICHAEL J | Director | Buy | P | 1.80 | 51,119 | 92,014 | 320,770 | 269.7 K to 320.8 K (+18.96 %) |
Mar 01 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 1.81 | 5,000 | 9,050 | 38,900 | 33.9 K to 38.9 K (+14.75 %) |
Mar 01 2007 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 1.82 | 10,000 | 18,200 | 33,900 | 23.9 K to 33.9 K (+41.84 %) |
Feb 27 2007 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 1.76 | 2,800 | 4,928 | 10,000 | 7.2 K to 10 K (+38.89 %) |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | ROHRER PHILIP L JR | Chief Financial Off ... | Option Exercise | A | 1.91 | 54,700 | 104,477 | 54,700 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Option Exercise | A | 3.25 | 16,662 | 54,152 | 16,662 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Option Exercise | A | 2.75 | 16,662 | 45,821 | 16,662 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Option Exercise | A | 2.25 | 16,662 | 37,490 | 16,662 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Option Exercise | A | 1.91 | 16,662 | 31,824 | 16,662 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Grant | A | 0.00 | 15,484 | 0 | 15,484 | 0 to 15.5 K |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Grant | A | 0.00 | 15,484 | 0 | 15,484 | 0 to 15.5 K |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | Tartaglia Louis A | SVP & GM Drug Repos ... | Option Exercise | A | 3.25 | 32,535 | 105,739 | 32,535 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | Tartaglia Louis A | SVP & GM Drug Repos ... | Option Exercise | A | 2.75 | 32,535 | 89,471 | 32,535 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | Tartaglia Louis A | SVP & GM Drug Repos ... | Option Exercise | A | 2.25 | 32,535 | 73,204 | 32,535 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | Tartaglia Louis A | SVP & GM Drug Repos ... | Option Exercise | A | 1.91 | 32,535 | 62,142 | 32,535 | |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | Tartaglia Louis A | SVP & GM Drug Repos ... | Grant | A | 0.00 | 60,471 | 0 | 60,471 | 0 to 60.5 K |
Jan 31 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.55 | 10,670 | 16,539 | 2,334,712 | 2.3 M to 2.3 M (+0.46 %) |
Feb 26 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | Director | Option Exercise | A | 1.91 | 30,000 | 57,300 | 30,000 | |
Jan 30 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.57 | 9,557 | 15,004 | 2,324,042 | 2.3 M to 2.3 M (+0.41 %) |
Jan 30 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.59 | 282,824 | 449,690 | 2,314,485 | 2 M to 2.3 M (+13.92 %) |
Jan 30 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.59 | 282,825 | 449,692 | 1,375,765 | 1.1 M to 1.4 M (+25.88 %) |
Jan 29 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.52 | 10,312 | 15,674 | 1,092,940 | 1.1 M to 1.1 M (+0.95 %) |
Jan 26 2007 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.52 | 7,768 | 11,807 | 1,082,628 | 1.1 M to 1.1 M (+0.72 %) |
Dec 04 2006 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.40 | 1,200 | 1,680 | 1,074,860 | 1.1 M to 1.1 M (+0.11 %) |
Nov 22 2006 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.38 | 300 | 414 | 1,058,571 | 1.1 M to 1.1 M (+0.03 %) |
Nov 22 2006 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.40 | 37,753 | 52,854 | 1,058,271 | 1 M to 1.1 M (+3.70 %) |
Nov 27 2006 | GLGC | ORE PHARMACEUTICAL ... | MILLER LLOYD I III | 10% Owner | Buy | P | 1.40 | 15,089 | 21,125 | 1,073,660 | 1.1 M to 1.1 M (+1.43 %) |
Jun 01 2006 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Option Exercise | A | 2.44 | 15,000 | 36,600 | 15,000 | |
Jun 01 2006 | GLGC | ORE PHARMACEUTICAL ... | BLAKE JULES PHD | Director | Option Exercise | A | 2.44 | 15,000 | 36,600 | 15,000 | |
Jun 01 2006 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | A | 2.44 | 15,000 | 36,600 | 15,000 | |
Jun 01 2006 | GLGC | ORE PHARMACEUTICAL ... | Douglas Frank L | Director | Option Exercise | A | 2.44 | 15,000 | 36,600 | 15,000 | |
Jun 01 2006 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 2.44 | 20,000 | 48,800 | 20,000 | |
Nov 04 2005 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 3.95 | 5,000 | 19,737 | 5,000 | 0 to 5 K |
Nov 02 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 3.98 | 1,500 | 5,970 | 7,200 | 5.7 K to 7.2 K (+26.32 %) |
Aug 25 2005 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 4.87 | 2,000 | 9,740 | 23,900 | 21.9 K to 23.9 K (+9.13 %) |
Aug 25 2005 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 4.87 | 1,500 | 7,305 | 21,900 | 20.4 K to 21.9 K (+7.35 %) |
Aug 25 2005 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 4.87 | 1,500 | 7,305 | 20,400 | 18.9 K to 20.4 K (+7.94 %) |
Aug 01 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 4.90 | 1,100 | 5,390 | 5,700 | 4.6 K to 5.7 K (+23.91 %) |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 3.41 | 20,000 | 68,200 | 20,000 | |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Option Exercise | A | 3.36 | 60,000 | 201,600 | 60,000 | |
Jun 07 2005 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | F | 0.15 | 5,625 | 844 | 0 | |
Jun 07 2005 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | F | 0.15 | 4,375 | 656 | 0 | |
Jun 07 2005 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Buy | P | 0.15 | 5,625 | 844 | 10,000 | 4.4 K to 10 K (+128.57 %) |
Jun 07 2005 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Buy | P | 0.15 | 4,375 | 656 | 4,375 | 0 to 4.4 K |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | Douglas Frank L | Director | Option Exercise | A | 3.41 | 15,000 | 51,150 | 15,000 | |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Option Exercise | A | 3.41 | 15,000 | 51,150 | 15,000 | |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | GORRY G ANTHONY PHD | Director | Option Exercise | A | 3.41 | 15,000 | 51,150 | 15,000 | |
Jun 03 2005 | GLGC | ORE PHARMACEUTICAL ... | BLAKE JULES PHD | Director | Option Exercise | A | 3.41 | 15,000 | 51,150 | 15,000 | |
May 27 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 3.29 | 200 | 658 | 4,600 | 4.4 K to 4.6 K (+4.55 %) |
May 27 2005 | GLGC | ORE PHARMACEUTICAL ... | THOMPSON J STARK PHD | Director | Buy | P | 3.30 | 1,200 | 3,958 | 4,400 | 3.2 K to 4.4 K (+37.50 %) |
Mar 11 2005 | GLGC | ORE PHARMACEUTICAL ... | Brinkerhoff Van Wyck | Sr. VP & General Ma ... | Option Exercise | A | 3.23 | 50,000 | 161,500 | 50,000 | |
Feb 02 2005 | GLGC | ORE PHARMACEUTICAL ... | STAPLES F DUDLEY JR | Senior VP, Secretar ... | Buy | J | 2.60 | 600 | 1,560 | 3,000 | 2.4 K to 3 K (+25.00 %) |
Feb 02 2005 | GLGC | ORE PHARMACEUTICAL ... | GESSLER MARK D | CEO and President | Buy | J | 2.60 | 600 | 1,560 | 196,521 | 195.9 K to 196.5 K (+0.31 %) |
Feb 02 2005 | GLGC | ORE PHARMACEUTICAL ... | ROHRER PHILIP L JR | Chief Financial Off ... | Buy | J | 2.60 | 600 | 1,560 | 11,850 | 11.3 K to 11.9 K (+5.33 %) |
Feb 02 2005 | GLGC | ORE PHARMACEUTICAL ... | Barger Dennis | VP Global Business ... | Buy | J | 2.60 | 600 | 1,560 | 600 | 0 to 600 |
Dec 06 2004 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Gift | G | 0.00 | 8,366 | 0 | 26,535 | 34.9 K to 26.5 K (-23.97 %) |
Nov 09 2004 | GLGC | ORE PHARMACEUTICAL ... | Smith-Farrell Joanne | VP Corp Development ... | Option Exercise | A | 3.50 | 30,000 | 105,000 | 30,000 | |
Sep 22 2004 | GLGC | ORE PHARMACEUTICAL ... | ROSSI DENNIS | GM Gene Logic Genom ... | Option Exercise | A | 3.93 | 50,000 | 196,500 | 50,000 | |
Sep 22 2004 | GLGC | ORE PHARMACEUTICAL ... | ROSSI DENNIS | GM Gene Logic Genom ... | Option Exercise | A | 3.93 | 50,000 | 196,500 | 50,000 | |
Aug 31 2004 | GLGC | ORE PHARMACEUTICAL ... | BRENNAN MICHAEL J | Director | Buy | P | 3.42 | 100 | 342 | 344,651 | 344.6 K to 344.7 K (+0.03 %) |
Aug 31 2004 | GLGC | ORE PHARMACEUTICAL ... | BRENNAN MICHAEL J | Director | Buy | P | 3.43 | 2,040 | 6,997 | 344,551 | 342.5 K to 344.6 K (+0.60 %) |
Aug 31 2004 | GLGC | ORE PHARMACEUTICAL ... | BRENNAN MICHAEL J | Director | Buy | P | 3.44 | 7,860 | 27,038 | 342,511 | 334.7 K to 342.5 K (+2.35 %) |
Aug 30 2004 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 3.40 | 1,000 | 3,400 | 34,901 | 33.9 K to 34.9 K (+2.95 %) |
Aug 26 2004 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 3.40 | 1,000 | 3,400 | 33,901 | 32.9 K to 33.9 K (+3.04 %) |
Aug 26 2004 | GLGC | ORE PHARMACEUTICAL ... | DIMMLER CHARLES L III | Director | Buy | P | 3.42 | 1,000 | 3,420 | 32,901 | 31.9 K to 32.9 K (+3.13 %) |